Group B streptococci (GBS) are the most common cause of pneumonia and sepsis during the neonatal period; however, the pathogenesis of this infection is poorly understood. We investigated the ability of GBS to enter epithelial cells in culture. Two strains of GBS were capable of invading immortalized respiratory epithelial cell lines in vitro at different levels, suggesting strain differences in invasiveness. Intracellular replication was not observed. Invasion required actin microfilaments but not microtubular cytoskeletal elements. Active bacterial protein, DNA, and RNA syntheses were required for invasion. These findings are consistent with our previous observation of intracellular GBS in the lungs of infected primates. We hypothesize that this organism may access the bloodstream by direct invasion of the epithelial cell barrier.
Streptococcus agalactiae and group B streptococci (GBS) are the most common causes of neonatal bacterial pneumonia, sepsis, and meningitis in the United States. Pneumonia develops as a consequence of aspiration of infected amniotic fluid in utero or from vaginal contents during parturition (1) . Once the organism gains access to the lungs, the pathogenesis of GBS pneumonia and how the organism gets into the bloodstream to cause overwhelming sepsis are unclear. We have observed these bacteria within alveolar epithelial and interstitial fibroblasts of the lung in a nonhuman primate model of GBS pneumonia and sepsis, suggesting that the organism actually enters these cells during the course of infection (17) . The following studies describe observations demonstrating that GBS are capable of entering cultured respiratory epithelial cells and characterize some of the important cellular and bacterial factors important for this process. These results suggest that direct invasion of lung epithelium is an important step in neonatal pneumonia and may allow the organism access to the bloodstream, resulting in systemic infection.
MATERLILS AND METHODS
Bacterial strains and cultures. Strain COH-1 is a type III clinical isolate from an infected infant with early-onset GBS pneumonia and sepsis (22) . Strain COH31r/s is a type III clinical isolate from a diabetic adult with a colonized foot ulcer (18) . A549 cells (American Type Culture Collection), a human alveolar epithelial carcinoma cell line, were used for all invasion assays and were grown as described below.
4MBr-5 bronchial epithelial cells (American Type Culture Collection) from nonhuman primates were also used in certain studies and were grown in Ham's F-12 medium with 10% fetal calf serum and 30 ng of epidermal growth factor per ml.
Epithelial cell invasion assays. Bacteria were grown to an optical density at 600 nm (OD6.) of 0.4 in Todd-Hewitt * Corresponding author.
broth, washed twice in phosphate-buffered saline (PBS, pH 7.0), and resuspended in RPMI-1640 tissue culture medium containing 10% fetal calf serum. GBS and Escherichia coli DH5 were inoculated onto A549 monolayers at 5 x 105 CFU/ml, centrifuged at 800 x g, and allowed to incubate for 2 h at 37°C in 5% CO2, and then extracellular bacteria were removed by washing four or five times with PBS. Tissue culture medium with penicillin (5 ,ug/ml) and gentamicin (100 ,ug/ml) (neither antibiotic penetrates eukaryotic cells [23] )
was added to the infected monolayers for 2 h at 37°C to kill any remaining extracellular bacteria. The medium was removed, the monolayers were washed as described above, the cells were lysed by treatment with 100 ,ul of 0.25% trypsin, and then 400 ,ul of 0.025% Triton X-100 in distilled H20 was added. The lysate was transferred to 1.5-ml Eppendorf tubes and vortexed vigorously for 10 s to disrupt streptococcal chains, as confirmed by Gram stain. Aliquots of the lysates were quantitatively plated on Todd-Hewitt agar plates to determine the number of intracellular bacteria. The same invasion assay was used for the growth phase experiments with organisms which were grown to specific optical densities and subsequently prepared for use in the invasion assay as described above. Experiments were performed in triplicate and replicated three times unless otherwise indicated. In these assays, the well array, plating effects across each culture plate, and plate-to-plate variability were determined as described before (2) . Statistical analyses were performed as described below. Invasion inhibition assays. Bacterial inocula were prepared as described above but resuspended in tissue culture medium (RPMI-1640) with the indicated concentrations of the inhibitor present for 30 min prior to infection and during the initial 2 h of incubation with the A549 monolayers. The supernatants were removed, and the number of viable bacteria was quantified; the remainder of the assay was performed as described above. Data are expressed as the percent invasion normalized to the control (COH-1 invasion in the absence of specific inhibitor = 100%). Tube dilution assays were used to determine the MICs (16) (3) .
RESULTS
The ability of GBS to enter epithelial cells in cultured monolayers of the human alveolar epithelial cell line A549 was determined in an assay essentially as described by Isberg and Falkow (12) . This assay is based on the inability of penicillin and gentamicin to enter epithelial cells, allowing quantification of intracellular bacteria after extracellular bacteria are killed. COH-1, a highly encapsulated serotype III clinical isolate (22) , was more invasive (Fig. 1) (0) organisms invading A549 cells over 8 h. The invasion assay was performed as described in the text except that the bacteria were allowed to incubate on the monolayers for the indicated times before the cells were washed and antibiotic-containing medium was added.
than the noninvasive control strain, E. coli DH5. When the length of incubation time was extended to 8 h before the supernatant was removed and antibiotic-containing medium was added, a significant increase in the number of recoverable intracellular COH-1 organisms was observed ( Fig. 2) , while the recovery of E. coli DH5 remained significantly lower. All differences were significant (P < 0.01). These data suggest that GBS strains differ in their ability to enter epithelial cells and that more GBS were recovered as the incubation time was increased.
The inoculum size of GBS used to infect the monolayers affected the number of recoverable intracellular organisms, as shown in Table 1 . As the inoculum increased, so did the number of recoverable bacteria. We observed that log differences in inoculum did not result in proportional changes in the number of bacteria recovered. The data were expressed as the mean total number of CFU recovered and, for comparison, as the percentage of the initial inoculum recovered (percent invasion). As can be seen, the percent invasion does not accurately reflect the observation that more bacteria are recovered from monolayers infected with a higher inoculum. Therefore, we preferred to express the data as the actual number of CFU recovered. These data suggested that a finite number of the bacteria in the initial inoculum can enter epithelial cells.
Organisms grown to different growth stages showed significant differences in their ability to invade epithelial monolayers at 2 and 4 h after infection (Fig. 3) . Stationary-phase were more invasive than lag-phase or log-phase thionine at any of the concentrations of cycloheximide used. 2 h, but more lag-phase organisms were recovNone of these drugs at any of the concentrations used Lnd 6 h postinfection. By 6 h, the differences were affected the viability or growth of GBS during the assays, as ent. These differences suggested that the stage of determined in independent MIC tests. y have significant effects on the initial kinetics of Inhibition of protein, RNA, and DNA synthesis in GBS had profound effects on invasion (Table 2) . COH-1 was lity of GBS to replicate within A549 cells was treated with antibiotics just above, at, and just below the d by adding tissue culture medium containing MIC during infection of A549 monolayers. The supernatants rnd gentamicin after GBS were allowed to invade were removed, the monolayers were washed with PBS, and )r 2 h and comparing invasion with that in control medium containing penicillin and gentamicin was added to bated without antibiotics at each time point. Wells kill extracellular bacteria. Intracellular bacteria are proted cells were subsequently sampled hourly for 8 tected from the bactericidal effects of penicillin and gentawere lysed, and the number of viable intracellular micin. Since GBS were treated with bacteriostatic concen-GBS was determined by quantitative plate counts. There was no significant increase in the number of intracellular bacteria over the 8-h incubation period (Fig. 4) . To ensure that the number of intracellular bacteria was not affected by the presence of both antibiotics over the 8-h period, control experiments were also performed with gentamicin alone. No differences were observed between wells treated with penicillin plus gentamicin and those treated with gentamicin alone (data not shown). These data suggested that the increased number of GBS recovered from the intracellular compartment over time was due to continued invasion rather than intracellular replication. Electron microscopy of infected monolayers confirmed the presence of intracellular GBS. Samples of monolayers were taken each hour for 8 h, fixed with glutaraldehyde, and processed for electron microscopy. As shown in Fig. 5A and B, within 1 h of addition of GBS to the monolayer, the bacteria were seen in close proximity to epithelial microvilli. In addition, some bacteria were associated with clathrincoated pits at the cell membrane, and microviuli were beginning to extend around individual bacterial cells. By 2 h, intracellular GBS were seen ( Fig. 5C and D trations of the other antibiotics, they remain viable and are free of the inhibitory effect once they enter the cell. This allowed us to determine the effects of different antibiotic concentrations at and around the bacteriostatic MIC on invasion of epithelial cells. Some bactericidal activity was observed at the concentration of antibiotic just above the MIC. Conversely, growth was observed at the suboptimal MIC but at lower levels than were observed for growth without antibiotic (data not shown).
Significant inhibition of invasion was observed at the MIC of all three antibiotics. More invasion was observed at the suboptimal MICs than at the MICs with minocycline and ciprofloxacin but not with rifampin. At concentrations above the MIC, when organism viability was decreased, less invasion by minocycline-and ciprofloxacin-treated GB3S was observed. Minocycline, a protein synthesis inhibitor, caused the most significant inhibition, suggesting that active protein synthesis by GBS was critical for invasion, as has been shown for other invasive mucosal pathogens (8) . The dependence on protein synthesis was confirmed by treating GBS with gentamicin at bacteriostatic concentrations prior to infection of the A549 monolayers; this treatment inhibited invasion to the same degree as minocycline treatment (data not shown). Rifampin, an RNA synthesis inhibitor, and ciprofloxacin, a DNA synthesis inhibitor, significantly inhibited invasion, although less markedly than observed after protein synthesis inhibition ( Table 2 ). All differences observed were significant at P < 0.01. These data demon- (17), showing GBS within membrane-bound vacuoles of type II alveolar epithelial cells (arrows). AL, alveolus; I, type I epithelium; II, type II epithelium; LB, lamellar bodies; GL, glycogen typical of immature lung cells; *, epithelial basement membrane. strated that active bacterial protein, RNA, and DNA synthesis was important for invasion.
DISCUSSION
We have provided data which demonstrate the ability of GBS to invade epithelial cells in vitro. Using an invasion assay similar to that described by Isberg and Falkow (12) and transmission electron microscopy, we have defined some of the characteristics important for entry of this organism into eukaryotic cells. Since gentamicin is bacteriostatic for GBS, we also used the bactericidal antibiotic penicillin to enhance killing of extracellular bacteria. No data on the ability of penicillin to enter epithelial cells are available; however, our control assays with gentamicin alone showed no significant difference in the number of viable intracellular bacteria recovered from infected monolayers treated with penicillin plus gentamicin or gentamicin alone. Stationary-phase and lag-phase organisms invaded cells more readily than logphase organisms. This suggests that factors important for invasion were expressed differently during specific phases of growth or that growth rates of GBS at different stages of growth in the tissue culture supernatant affected invasion.
Significantly more intracellular organisms were recovered from epithelial monolayers infected with a larger inoculum without apparent untoward effects on the morphology of the epithelium. However, the number of intracellular bacteria recovered was not proportional to the inoculum size, suggesting that a finite number of GBS were able to invade at a particular time. Whether this reflects a limited population of GBS able to stimulate phagocytosis by the epithelial cells or a limited epithelial cell response to stimulation for phagocytosis is unclear. Increasing numbers of intracellular bacteria were recovered when the organism was left in contact with the epithelium for increasing lengths of time. We have observed that the organism grows rapidly in the supernatant (data not shown), and this may provide a larger pool of GBS that are able to invade at each subsequent time point. Alternatively, we considered that the organism may replicate once inside the epithelium.
Some invasive bacteria replicate once they are internalized by eukaryotic cells (5 copy also demonstrated the lack of epithelial cell degeneration as a consequence of internalization of the organism. How this pathogen evades intracellular antibacterial mechanisms was not addressed by our studies. Active protein, RNA, and DNA synthesis by GBS was required, suggesting that de novo bacterial metabolism is critical for the invasive process. Bacterial invasion was observed even at suboptimal MICs of the antibiotics, which allowed some bacterial growth, providing further support for these conclusions. This suggests that constitutive expression or induction of a specific "invasion" gene(s) occurs when the bacteria are in the appropriate environment, as observed for salmonellae (13) . Invasion of the epithelium by Salmonella and Shigella spp. also requires active RNA and protein synthesis, but inhibition of DNA synthesis had no effect (6, 9, 11) . In contrast, organisms such as yersinias continue to invade despite treatment with Formalin, UV light inactivation, or inhibition with RNA and protein synthesis inhibitors (5, 14, 21) . We are currently investigating the specific proteins which may be expressed by GBS in response to epithelial cells.
The uptake of GBS by otherwise nonprofessional phagocytes required actin microfilament function but not microtubules. These findings are similar to those observed for enteric and other respiratory mucosal pathogens (4, 7, 10, 15, 19) . De novo protein synthesis by the epithelium was not required for bacterial uptake, as observed for salmonellae (9) .
These data extend our previous observations of GBS entering alveolar epithelial cells in a nonhuman infant primate model of GBS pneumonia and sepsis that mimics human disease (17) . Both GBS strains tested invaded epithelial cells but to different degrees, suggesting strain-to-strain variability in ability to enter eukaryotic cells. These differences were observed for both respiratory epithelial cell lines tested. Although both strains are type III GBS, the differences in these two strains have become more apparent as we continue to study them. For example, COH-1 was isolated from an infected infant, whereas COH31 was isolated from a diabetic patient with a foot ulcer that was not actively infected. Strain COH-1 is heavily encapsulated, less susceptible to phagocytic killing by polymorphonuclear leukocytes, and more virulent in animal models than COH31. Therefore, the differences in their ability to invade the epithelium may also reflect inherent differences in their ability to cause infections as well. We are currently exploring the role of encapsulation in epithelial cell invasion.
Prior to these observations, it was unclear how GBS traversed the epithelial cell barrier. We postulate that GBS enter epithelial cells directly as a first step in traversing the epithelial cell barrier of the newborn lung in the pathogenesis of pneumonia, which ultimately allows the organism to enter the bloodstream and to disseminate systemically. The intracellular environment may protect the organism from other host defense mechanisms and antibiotics. Experiments are in progress to develop our understanding of the role of the epithelial cell invasion process as an important virulence mechanism in the pathogenesis of GBS infections.
